Dreyer Scott (CIK 1746251) reported 24 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Sell COLL (46,417 shares), Sell COLL (3,559 shares), Buy COLL (19,023 shares), Buy COLL (30,702 shares), Sell COLL (9,977 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 46,417 | $1.9M |
| 2026-03-05 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 3,559 | $145,883 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 19,023 | $0 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 30,702 | $0 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 9,977 | $466,425 |
| 2026-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 21,615 | $1.0M |
| 2025-12-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 17,600 | $279,840 |
| 2025-12-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 11,125 | $532,776 |
| 2025-12-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 6,475 | $315,074 |
| 2025-08-20 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 16,389 | $349,741 |
| 2025-08-20 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 16,389 | $626,224 |
| 2025-08-15 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 4,861 | $184,864 |
| 2025-08-15 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 4,861 | $103,734 |
| 2025-03-24 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 1,927 | $57,810 |
| 2025-03-24 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 18,881 | $566,996 |
| 2025-03-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 15,387 | $461,610 |
| 2025-03-18 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 2,255 | $67,650 |
| 2025-03-13 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 15,387 | $461,610 |
| 2025-03-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 3,295 | $98,850 |
| 2025-03-10 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 2,348 | $70,440 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 45,016 | $0 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Buy | 26,411 | $0 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 7,953 | $242,726 |
| 2025-02-12 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | EVP & Chief Commercial Officer | Sell | 21,670 | $661,368 |
Source: SEC Form 4 filings · as of 2026-03-05